Stereotactic Body Radiation Therapy trials for Lung cancer

All Stereotactic Body Radiation Therapy trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Stereotactic Body Radiation Therapy for Lung cancer

• A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab
  NCT07619599 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma
  NCT06014827 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung Cancer
  NCT03422302 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC
  NCT06623656 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study
  NCT05802186 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors
  NCT03392233 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
  NCT05624996 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 477 locations
• The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer
  NCT06738160 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Stereotactic Body Radiation Therapy for Lung cancer?

8 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.